Literature DB >> 19827961

Benefits and challenges in use of a standardized symptom assessment instrument in hospice.

Dena Schulman-Green1, Emily J Cherlin, Ruth McCorkle, Melissa D A Carlson, Karen Beckman Pace, Janet Neigh, Meliessa Hennessy, R Johnson-Hurzeler, Elizabeth H Bradley.   

Abstract

BACKGROUND: Hospices are now mandated to perform routine quality assessment under the final Medicare Hospice Conditions of Participation, creating an opportunity to explore standardized approaches to monitoring hospice quality.
OBJECTIVE: We report hospice staff experiences using a standardized symptom assessment instrument, the Edmonton Symptom Assessment System (ESAS), in a pilot study designed to develop and test quality measures on symptom management. Use of the ESAS illustrates the benefits and challenges arising with standardized symptom assessment for quality monitoring in hospice.
METHODS: We interviewed 24 individuals representing 8 hospices involved with the National Association for Home Care & Hospice Quality Assessment Collaborative, which pilot tested the ESAS as a source of standardized data for quality assessment. Transcripts were analyzed using the constant comparative method.
RESULTS: Participants reported benefits and challenges with the ESAS. Benefits were that the ESAS was a brief and easy tool that identified areas of concern, engaged patients in symptom assessment, and monitored symptom changes over time. Additionally, the ESAS was viewed as a useful teaching tool for less experienced staff. Challenges included lack of clarity about inclusion rules and frequency of assessments; difficulty interpreting the numeric symptom rating scale, difficulty incorporating patient preferences with symptoms, and a sense that the use of standard assessment instruments was "unnatural." DISCUSSION: Recommendations to promote effective use of ESAS data for quality monitoring of hospice care include standardizing implementation procedures, adding patients' preferences to the ESAS form, and staff education to enhance comfort with the instrument before implementation.

Entities:  

Mesh:

Year:  2010        PMID: 19827961      PMCID: PMC2883490          DOI: 10.1089/jpm.2009.0245

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  13 in total

1.  Qualitative data analysis for health services research: developing taxonomy, themes, and theory.

Authors:  Elizabeth H Bradley; Leslie A Curry; Kelly J Devers
Journal:  Health Serv Res       Date:  2007-08       Impact factor: 3.402

Review 2.  The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991--2006).

Authors:  Cheryl Nekolaichuk; Sharon Watanabe; Crystal Beaumont
Journal:  Palliat Med       Date:  2008-03       Impact factor: 4.762

3.  The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK.

Authors:  E Rees; J Hardy; J Ling; K Broadley; R A'Hern
Journal:  Palliat Med       Date:  1998-03       Impact factor: 4.762

4.  The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients.

Authors:  E Bruera; N Kuehn; M J Miller; P Selmser; K Macmillan
Journal:  J Palliat Care       Date:  1991       Impact factor: 2.250

5.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Authors:  C S Cleeland; T R Mendoza; X S Wang; C Chou; M T Harle; M Morrissey; M C Engstrom
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

6.  Time course and characteristics of symptom distress and quality of life at the end of life.

Authors:  Jean S Kutner; Lucinda L Bryant; Brenda L Beaty; Diane L Fairclough
Journal:  J Pain Symptom Manage       Date:  2007-06-14       Impact factor: 3.612

7.  The Edmonton symptom assessment system--what do patients think?

Authors:  Sharon Watanabe; Cheryl Nekolaichuk; Crystal Beaumont; Asifa Mawani
Journal:  Support Care Cancer       Date:  2008-10-25       Impact factor: 3.603

8.  Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale.

Authors:  Joan E Tranmer; Daren Heyland; Debra Dudgeon; Dianne Groll; Mae Squires-Graham; Kathy Coulson
Journal:  J Pain Symptom Manage       Date:  2003-05       Impact factor: 3.612

9.  The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

Authors:  R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

Review 10.  Use of family proxies in quality of life research for cancer patients at the end of life: a literature review.

Authors:  Siew Tzuh Tang; Ruth McCorkle
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

View more
  8 in total

1.  Health care providers' use and knowledge of the Edmonton Symptom Assessment System (ESAS): is there a need to improve information and training?

Authors:  Daniela Carli Buttenschoen; Jarad Stephan; Sharon Watanabe; Cheryl Nekolaichuk
Journal:  Support Care Cancer       Date:  2013-09-13       Impact factor: 3.603

2.  Tell Us™: a Web-based tool for improving communication among patients, families, and providers in hospice and palliative care through systematic data specification, collection, and use.

Authors:  Sydney M Dy; Jayashree Roy; Geoffrey E Ott; Michael McHale; Christine Kennedy; Jean S Kutner; Allen Tien
Journal:  J Pain Symptom Manage       Date:  2011-03-31       Impact factor: 3.612

3.  Experiences of participants in a collaborative to develop performance measures for hospice care.

Authors:  Dena Schulman-Green; Emily Cherlin; Karen Beckman Pace; Meliessa Hennessy; Patricia A Crocker; Elizabeth H Bradley
Journal:  Jt Comm J Qual Patient Saf       Date:  2011-01

Review 4.  Perceived benefits and limitations of using patient-reported outcome measures in clinical practice with individual patients: a systematic review of qualitative studies.

Authors:  Rachel Campbell; Angela Ju; Madeleine T King; Claudia Rutherford
Journal:  Qual Life Res       Date:  2021-09-27       Impact factor: 4.147

Review 5.  Symptom assessment to guide treatment selection and determine progression in metastatic castration-resistant prostate cancer: Expert opinion and review of the evidence.

Authors:  Fred Saad; Frédéric Pouliot; Brita Danielson; Charles Catton; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2018-05-14       Impact factor: 1.862

6.  Edmonton Symptom Assessment Scale Time Duration of Self-Completion Versus Assisted Completion in Patients with Advanced Cancer: A Randomized Comparison.

Authors:  Angelique Wong; Supakarn Tayjasanant; Alfredo Rodriguez-Nunez; Minjeong Park; Diane Liu; Kresnier Perez Zapata; Julio Allo; Susan Frisbee-Hume; Janet Williams; Eduardo Bruera
Journal:  Oncologist       Date:  2020-12-21       Impact factor: 5.837

7.  Use of Opioids and Sedatives at End-of-Life.

Authors:  Shin Wei Sim; Shirlynn Ho; Radha Krishna Lalit Kumar
Journal:  Indian J Palliat Care       Date:  2014-05

8.  Experiencing improved assessment and control of pain in end-of-life care when using the Abbey Pain Scale systematically.

Authors:  Carola Ludvigsson; Ulf Isaksson; Senada Hajdarevic
Journal:  Nurs Open       Date:  2020-07-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.